Venture • Life Science

Eight Roads Invests In Shanghai Hile Bio-Technology

On April 4, 2010, private equity firm Eight Roads invested in life science company Shanghai Hile Bio-Technology

Investment Context
  • This is Eight Roads’ 10th transaction in the Life Science sector.
  • This is Eight Roads’ 11th transaction in China.
Investment Fate
  • Shanghai Hile Bio-Technology went public in 2015.

Explore All 557 Venture Life Science Deals - Search the Database Free


Investment Summary

Date April 4, 2010
Target Shanghai Hile Bio-Technology
Sector Life Science
Investor(s) Eight Roads
Deal Type Venture

Target Company

Shanghai Hile Bio-Technology

Shanghai, China
Shanghai Hile Bio-Technology researches, develops, produces, and sells veterinary biological products for livestock and poultry in China. Shanghai Hile Bio-Technology was founded in 1981 and is based in Shanghai, China.
Explore More Deals

Browse All 215,156 Deals

FILTER BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Search Free

Investor Overview 1

Investor

Eight Roads

Investor Investor Investor Investor Investor


Category Private Equity Firm
Founded 1969
PE ASSETS 11.0B USD
Size Mega
Type Sector Focused
DESCRIPTION

Eight Roads is a private investment firm focused on a variety of investment opportunities across the US, Europe, and Asia. The Firm is divided into several investment strategies including venture, principal investing, and real estate. Within the principal investments group, Eight Roads backs established growth businesses with long-term capital. Eight Roads does not have any sector preferences, but has experience in fintech, business services, and healthcare. Eight Roads is based in London.


Deal Context for Investor #
Overall 23 of 293
Sector: Life Science 10 of 73
Type: Venture 17 of 266
Country: China 11 of 66
Year: 2010 3 of 8
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2010-02-12 Ironwood Pharmaceuticals

Boston, Massachusetts, United States

Ironwood Pharmaceuticals is a healthcare company, that focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZESS name in the United States and Mexico, as well as under the CONSTELLA name in the Canada and European Union. Ironwood Pharmaceuticals was founded in 1998 and is based in Boston, Massachusetts.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2010-05-10 PL Engineering

Gurgaon, India

PL Engineering provides engineering services outsourcing player with a focus on oil & gas, power and infrastructure. The Company provides a wide range of services including basic design, detailed design and engineering / construction drawings. PL Engineering is based in Gurgaon, India.

Buy -

Explore Related M&A Activity